SCN2A-Related Disorders

— —

Alfred L. George, Jr. (Northwestern University Feinberg School of Medicine) Megan Abbott (University of Colorado School of Medicine)

SCN2A-Related Disorders

Alfred L. George, Jr. (Northwestern University Feinberg School of Medicine), Megan Abbott (University of Colorado School of Medicine), Kevin J. Bender (University of California, San Francisco) , Andreas Brunklaus (Royal Hospital for Children and University of Glasgow)

$96.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Cambridge University Press
02 January 2025

Medical genetics; Neurology & clinical neurophysiology; Neurosciences; Developmental biology

Series: Elements in Genetics in Epilepsy

SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families.

This title is also available as Open Access on Cambridge Core.

By: Megan Abbott (University of Colorado School of Medicine), Kevin J. Bender (University of California, San Francisco), Andreas Brunklaus (Royal Hospital for Children and University of Glasgow), Scott Demarest (University of Colorado School of Medicine)
Edited by: Alfred L. George Jr. (Northwestern University Feinberg School of Medicine)
Imprint: Cambridge University Press
Country of Publication: United Kingdom
ISBN: 9781009530330
ISBN 10: 100953033X
Series: Elements in Genetics in Epilepsy
Pages: 96
Publication Date: 02 January 2025
Audience: General/trade , ELT Advanced
Format: Hardback
Publisher's Status: Active

Introduction; Patient, Family and Foundation Perspectives; Clinical Spectrum and Genotype-Phenotype Correlations; The Biology of SCN2A; Treatment of SCN2A-Related Disorders; Abbreviations; Appendix; References.